期刊文献+

硫糖铝对幽门螺杆菌VacA IgY的保护作用的动物实验评价 被引量:5

Evaluation on protective effects of sucralfate on H.pylori-VacA-IgY in animal experiments
原文传递
导出
摘要 目的评价硫糖铝在胃内对H.pyloriVacA IgY型抗体的保护作用,为制备H.pyloriVacA IgY型抗体口服剂提供实验依据。方法大量诱导工程菌DH5α-vacA-pQE30,表达并纯化重组蛋白VacA。以VacA为抗原接种洛曼母鸡,制备纯化的IgY。建立H.pylori感染的小鼠模型,在不同浓度的IgY液中分别加入30%硫糖铝,灌胃后观察胃黏膜慢性炎症反应以评价硫糖铝在胃内对VacA IgY的保护作用。结果在小鼠胃内,0.5mg IgY+30%硫糖铝/天灌胃小鼠即可有效防治H.pylori感染引起的胃黏膜损害,与不加硫糖铝比较,其效果提高了8倍。结论 30%以上的硫糖铝在小鼠胃内可增强VacA IgY对低pH和胃蛋白酶的耐受能力,是较理想的抗H.pyloriVacA IgY型抗体保护剂。 Objective To evaluate the protective effects of suczalfate on anti-H, pylori VacA immunoglobulin yolk (VacA IgY) intragastricalIy and provide experimental basis for preparation of oral-administration IgY. Method The recombinant vacuolate cytotoxin antigen(VacA) was expressed in engineering bacteria DHSct-vacA-pQE30 and purified. VacA IgY was prepared by inoculating purified VacA in Lohman hens and then depurated. Mice infected by H. py/or/were intragastrically administered 30% sucralfate and IgY solutions of different concentrations. The chronic inflammstory reaction of gastric mucosa was observed to evaluate the protective effects of sucralfate on VacA IgY in stomach. Result Intragastric administration with 0.5 mg IgY plus 30% sueralfate per day could effectively prevent and cure the injury of gastric mucosa caused by 1t. pylori infection. The protective effect of VacA IgY group containing 30% sucralfate was eight times as that of the groups without sucralfate. Conclusion 30% or higher concentration of sucralfate can enhance the tolerance of VacA IgY to low pH value and pepsin intragastrically and may be an ideal protectant for IgY.
出处 《中国微生态学杂志》 CAS CSCD 2010年第11期988-992,共5页 Chinese Journal of Microecology
基金 重庆市科委基金(CSTC 2005EA5020)
关键词 幽门螺杆菌 细胞空泡毒素抗原 卵黄抗体 硫糖铝 保护剂 Helicobacter pylori Vacuolate cytotoxin antigen Immunoglobulin yolk Sucralfate Pretectant
  • 相关文献

参考文献15

  • 1GRANSTROM M, TINDBERG Y, BLENNOW M. Seroepidemiology of Helicobacter pylori infection in a cohort of children monitored from 6 months to 11 years of age[J]. J Clin Microbiol,1997,35(2) :468-470.
  • 2SALIH B A. Helicobacter pylori infection in developing countries: the burden for how long7 [ J ]. Saudi J Gastroenterol, 2009,15 ( 3 ) : 201- 207.
  • 3International Agency for Research on Cancer. Schistosomes,liver flukes and Helicobacter pylori[ M ]. IARC Monograph on the Evaluation of Carcinggenic Risks to Human. 1994, Vo161, Lyon: IARC.
  • 4MINE Y, KOVACS-NOLAN J. Chiken egg yolk antibodies as therapeutics in enteric infections disease[J]. J Med Food,2002,5(3) : 159- 169.
  • 5SUZUKI H,NOMURA S,MASAOKA T,et al. Effect of dietary anti-Helicobacter pylori-urease immunoglobulin Y on Helicobacter pylori infection[ J]. Aliment Pharmacol Therap ,2004,20( Suppl 1 ) : 185-192.
  • 6夏丽君,田一玲,杨致邦,黄伟,张任飞,李昌庆.抗重组VacA IgY体内抗幽门螺杆菌感染的实验研究[J].中国微生态学杂志,2008,20(5):446-449. 被引量:2
  • 7KIYOSHIGE O. Chemistriy of sueralfate[ M ]. New York : Pienum Medical book Company,1995:47-58.
  • 8郭丽媛,杨致邦,田一玲,黄伟,夏丽君,范贵荣,苏善平.抗幽门螺杆菌重组VacA卵黄抗体保护剂的探讨[J].中国病原生物学杂志,2009,4(3):182-186. 被引量:1
  • 9刘淼,杨致邦,林珊珊,吴利先.幽门螺杆菌细胞空泡毒素基因毒性片段的克隆与表达[J].重庆医科大学学报,2003,28(6):720-723. 被引量:12
  • 10毛小琴,杨致邦,黄伟,张绍兰,田一玲,叶翠莲.幽门螺杆菌重组VacA蛋黄抗体的制备[J].中国生物制品学杂志,2006,19(5):502-504. 被引量:2

二级参考文献60

共引文献26

同被引文献35

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部